𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome

✍ Scribed by Peiró, G; Mayr, D; Hillemanns, P; Löhrs, U; Diebold, J

Book ID
109887859
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
227 KB
Volume
17
Category
Article
ISSN
0893-3952

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of Her-2/neu oncogene in breas
Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens
✍ Fan Lin; Ting Shen; Jeffrey W. Prichard, 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Determination of Her-2/neu oncogene amplification is important in the current treatment of breast carcinoma. In addition to fluorescence in situ hybridization (FISH) and immunohistochemical stain (HercepTest 1 ), chromogenic in situ hybridization (CISH) has been shown to be a sensitive and specific

HER-2/neu amplification by fluorescence
HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma
✍ Bozzetti, Cecilia ;Personeni, Nicola ;Nizzoli, Rita ;Guazzi, Annamaria ;Flora, M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

BACKGROUND. Amplification of the HER-2/neu oncogene has been proposed as a target for antibody-based therapies and as a predictor of chemoresponsiveness in advanced breast carcinoma. Few studies have concentrated on HER-2/neu gene evaluation by fluorescence in situ hybridization (FISH) on distant me

HER-2/NEU gene amplification in breast i
HER-2/NEU gene amplification in breast imprint cytology analyzed by fluorescence in situ hybridization: Direct comparison with companion tissue sections
✍ Jeffrey G. Moore; Viet To; Shobha J. Patel; Nour Sneige 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

Fluorescence in situ hybridization (FISH) is a validated method for detection of HER-2/neu gene amplification and was recently approved by the FDA for diagnostic use in paraffin-embedded tissue. Its use in cytologic specimens, however, has not been investigated. To see whether HER-2/neu gene amplifi